Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|June 5, 1990
Conversion of recombinant hirudin to the natural form by in vitro tyrosine sulfation. Differential substrate specificities of leech and bovine tyrosylprotein sulfotransferasesC Niehrs, W B Huttner, D Carvallo, et al.
The Journal of Clinical Investigation|February 1, 1986
Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragmentM Schapira, M A Ramus, S Jallat, et al.
Archives of Biochemistry and Biophysics|March 1, 1987
Purification and characterization of human bronchial proteinase inhibitorC Boudier, D Carvallo, C Roitsch, et al.
Protein Engineering|October 1, 1986
Altered specificities of genetically engineered alpha 1 antitrypsin variantsS Jallat, D Carvallo, L H Tessier, et al.
The Journal of Clinical Investigation|August 1, 1987
Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragmentM Schapira, M A Ramus, B Waeber, et al.
European Journal of Biochemistry|March 15, 1988
Characterisation of two differently processed forms of human recombinant factor IX synthesised in CHO cells transformed with a polycistronic vectorA Balland, T Faure, D Carvallo, et al.
Nature|March 12, 1987
Molecular cloning of a protective antigen of schistosomesJ M Balloul, P Sondermeyer, D Dreyer, et al.
Biochemistry|April 4, 1989
Purification and biochemical characterization of recombinant hirudin produced by Saccharomyces cerevisiaeN Riehl-Bellon, D Carvallo, M Acker, et al.
Pageof 1